| Particulars (Rupees in Crores.) | Sept-2025 | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 |
|---|---|---|---|---|---|
Gross Sales | 438.48 | 421.55 | 361.2 | 407.28 | 301.98 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 438.48 | 421.55 | 361.2 | 407.28 | 301.98 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.03 | 3.55 | 2.67 | 3.14 | 1.32 |
Total Income | 440.5 | 425.1 | 363.87 | 410.42 | 303.31 |
Total Expenditure | 350.74 | 347.53 | 296.22 | 344.67 | 247.98 |
PBIDT | 89.76 | 77.57 | 67.65 | 65.75 | 55.33 |
Interest | 11.58 | 9.27 | 9.27 | 11.56 | 11.89 |
PBDT | 78.18 | 68.3 | 58.38 | 54.19 | 43.43 |
Depreciation | 19.77 | 17.34 | 17 | 15.92 | 15.59 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 13.25 | 9.64 | 10 | 8.63 | 6.5 |
Deferred Tax | 1.32 | 4.16 | 1.14 | 1.29 | 0.49 |
Reported Profit After Tax | 43.84 | 37.16 | 30.24 | 28.34 | 20.86 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 45.8 | 38.56 | 30.58 | 28.76 | 21.07 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 45.8 | 38.56 | 30.58 | 28.76 | 21.07 |
EPS (Unit Curr.) | 5.13 | 4.35 | 3.61 | 3.4 | 2.49 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 9.37 | 8.87 | 8.47 | 8.47 | 8.47 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 20.47 | 18.4 | 18.72 | 16.14 | 18.32 |
PBDTM(%) | - | - | - | - | - |
PATM(%) | 9.99 | 8.81 | 8.37 | 6.95 | 6.9 |
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.